T0	MultiCitation 1519 1523	[32]
T1	Context 1329 1524	The 3xTg-AD15-18 mice were treated for 3 months based on previous studies showing that in young mice 10-12 weeks of rapamycin administration is sufficient to reduce soluble Aβ and tau [29], [32].
T2	MISQUOTE 11548 11670	rapamycin did not alter Aβ40 levels but significantly decreased soluble Aβ42 levels in the brains of transgenic PDAPP mice
